W.G. Shaheen & Associates Dba Whitney & CO Bridge Bio Pharma, Inc. Transaction History
W.G. Shaheen & Associates Dba Whitney & CO
- $963 Million
- Q2 2025
A detailed history of W.G. Shaheen & Associates Dba Whitney & CO transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, W.G. Shaheen & Associates Dba Whitney & CO holds 12,000 shares of BBIO stock, worth $752,760. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,000
Previous 12,000
-0.0%
Holding current value
$752,760
Previous $414,000
25.12%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
419Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.16 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.03 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$832 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$781 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$582 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.3B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...